Academia Europaea, the European Molecular Biology Organization, the New York Academy of Sciences, Gesellschaft fur Immunologie, the American Association of Immunologists, and the Scandinavian Society for Immunology. Dr. von Boehmer has been awarded the Louis Jeantet Prize for Medicine, the Avery-Landsteiner Prize for Immunology, the Paul Ehrlich and Ludwig Darmstaedt Prize, and the Korber Prize for European Science. He chairs the Executive Committee of the European Journal of Immunology.
Max D. Cooper received his MD (1957) and training in Pediatrics (1958-1960) at Tulane Medical School. He was a house officer and research assistant at the Hospital for Sick Children, London(1960-1961), and a pediatric-allergy fellow at the University of California, San Francisco Medical Center (1961-1962). His postdoctoral research in the laboratory of Robert Good (1963-1967), led to the definition of separate T- and B-cell lineages. Dr. Cooper is professor of medicine, pediatrics, pathology, and microbiology at the University of Alabama at Birmingham; senior scientist at the University of Alabama Comprehensive Cancer Center; professor of medicine and director of the Division of Developmental and Clinical Immunology at the University of Alabama; and a Howard Hughes Medical Investigator. He is a member of the National Academy of Sciences and in 1990 was elected to the Institute of Medicine. He was inducted as a fellow in the American Association for the Advancement of Science. Dr. Cooper served as president of the American Association of Immunologists and of the Clinical Immunology Society. Among his awards are the 3M Life Sciences Award, the Sandoz Prize for Immunology, and the American College of Physicians Award.
Irwin Feller is the director of the Institute for Policy Research and Evaluation and professor of economics at the Pennsylvania State University, where he has been on the faculty since 1963. Dr. Feller was an American Society for Mechanical Engineering Pennsylvania State Fellow for 1996-1997. Dr. Feller's research interests include the economics of academic research, the university's role in technology-based economic development, and the evaluation of federal and state technology programs. He was chair of the Committee on Science, Engineering, and Public Policy, American Association for the Advancement of Science.
Laurie H. Glimcher received her MD at Harvard Medical School in 1976. She was an intern and resident at Massachusetts General Hospital and a postdoctoral fellow under the direction of William Paul at the National Institutes of Health. Dr. Glimcher is a physician in the Division of Rheumatology and Immunology at Brigham and Women's Hospital, professor of medicine at Harvard Medical School, and Irene Heinz Given Professor of Immunology at the Harvard School of Public Health. She received a Merit Award from NIH, was elected into the American Academy of Arts and Sciences, and received the Lee S. Howley Award from the Arthritis Foundation. She serves on the corporate board of directors for Bristol-Myers Squibb. She is a councilor of the American Association of Immunologists.
David V. Goeddel received his PhD in biochemistry in 1977 from the University of Colorado in Boulder. He was a postdoctoral fellow at the Stanford Research Institute. Dr. Goeddel is the president and chief executive officer of Tularik, Inc. He is a fellow of the American Association for the Advancement of Science and a member of the American Academy of Arts and Sciences, the National Academy of Sciences, and the American Academy of Microbiology. Dr. Goeddel serves on the editorial review boards of Immunity and Nature Biotechnology. His research interests include cytokine signaling mechanisms and small-molecule therapeutics that act through regulation of gene expression.